GeneDx Holdings Corp (NASDAQ: WGS) kicked off on Monday, up 4.56% from the previous trading day, before settling in for the closing price of $96.63. Over the past 52 weeks, WGS has traded in a range of $8.63-$115.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 16.51% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 248.68%. With a float of $24.53 million, this company’s outstanding shares have now reached $28.02 million.
In an organization with 1000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 60.75%, operating margin of -7.24%, and the pretax margin is -17.22%.
GeneDx Holdings Corp (WGS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of GeneDx Holdings Corp is 12.60%, while institutional ownership is 86.14%. The most recent insider transaction that took place on Apr 14 ’25, was worth 25,260,000. Before that another transaction happened on Apr 09 ’25, when Company’s CHIEF FINANCIAL OFFICER sold 15,516 for $92.18, making the entire transaction worth $1,430,334. This insider now owns 1,726 shares in total.
GeneDx Holdings Corp (WGS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 248.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 119.03% during the next five years compared to 96.65% growth over the previous five years of trading.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Take a look at GeneDx Holdings Corp’s (WGS) current performance indicators. Last quarter, stock had a quick ratio of 3.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.99, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 1.89 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.98 million. That was inferior than the volume of 1.03 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 88.92%. Additionally, its Average True Range was 8.97.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 74.45%, which indicates a significant decrease from 94.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.27% in the past 14 days, which was lower than the 102.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $90.10, while its 200-day Moving Average is $63.89. However, in the short run, GeneDx Holdings Corp’s stock first resistance to watch stands at $103.29. Second resistance stands at $105.54. The third major resistance level sits at $108.31. If the price goes on to break the first support level at $98.27, it is likely to go to the next support level at $95.50. The third support level lies at $93.25 if the price breaches the second support level.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
The company with the Market Capitalisation of 2.84 billion has total of 28,068K Shares Outstanding. Its annual sales at the moment are 305,450 K in contrast with the sum of -52,290 K annual income. Company’s last quarter sales were recorded 95,640 K and last quarter income was 5,440 K.
